Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
January 18, 2024
Imaging of Extravasation of Splenocytes in the Dorsal Skinfold Window Chamber
Tim Bozic, Bostjan Markelc
Methods in Molecular Biology (Clifton, N.J.)
|
January 18, 2024
Partial-Volume Irradiation of Murine Tumors
Ziva Modic, Bostjan Markelc, Tanja Jesenko
Cancers
|
September 13, 2025
Time- and Dose-Dependent Effects of Irradiation on Endothelial and Tumor Endothelial Cells: Transcriptional, Molecular, and Functional Changes Driving Activation In Vitro and In Vivo
Iva Santek, Gregor Sersa, Bostjan Markelc
Plos One
|
April 5, 2013
Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels
Bostjan Markelc, Gregor Sersa, Maja Cemazar
Plos One
|
March 21, 2015
Modeling of microvascular permeability changes after electroporation
Selma Corovic, Bostjan Markelc, Mitja Dolinar, et al.
Frontiers in Immunology
|
June 12, 2023
The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent
Barbara Lisec, Bostjan Markelc, Katja Ursic Valentinuzzi, et al.
Radiology and Oncology
|
April 21, 2025
Efficient gene transfer by pulse parameters for electrochemotherapy of cells <i>in vitro</i> and in muscle and melanoma tumors in mice
Masa Omerzel, Bostjan Markelc, Simona Kranjc Brezar, et al.
Bioelectrochemistry (Amsterdam, Netherlands)
|
May 13, 2021
PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice
Masa Bosnjak, Tanja Jesenko, Bostjan Markelc, et al.
Bioelectrochemistry (Amsterdam, Netherlands)
|
June 14, 2021
Corrigendum to "PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice" [Bioelectrochemistry 2021 (140) 107832]
Masa Bosnjak, Tanja Jesenko, Bostjan Markelc, et al.
Molecular Therapy. Nucleic Acids
|
October 29, 2014
Mcam Silencing With RNA Interference Using Magnetofection has Antitumor Effect in Murine Melanoma
Lara Prosen, Bostjan Markelc, Tanja Dolinsek, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Methods in Molecular Biology (Clifton, N.J.)
|
January 18, 2024
Imaging of Extravasation of Splenocytes in the Dorsal Skinfold Window Chamber
Tim Bozic, Bostjan Markelc
Methods in Molecular Biology (Clifton, N.J.)
|
January 18, 2024
Partial-Volume Irradiation of Murine Tumors
Ziva Modic, Bostjan Markelc, Tanja Jesenko
Cancers
|
September 13, 2025
Time- and Dose-Dependent Effects of Irradiation on Endothelial and Tumor Endothelial Cells: Transcriptional, Molecular, and Functional Changes Driving Activation In Vitro and In Vivo
Iva Santek, Gregor Sersa, Bostjan Markelc
Plos One
|
April 5, 2013
Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels
Bostjan Markelc, Gregor Sersa, Maja Cemazar
Plos One
|
March 21, 2015
Modeling of microvascular permeability changes after electroporation
Selma Corovic, Bostjan Markelc, Mitja Dolinar, et al.
Frontiers in Immunology
|
June 12, 2023
The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent
Barbara Lisec, Bostjan Markelc, Katja Ursic Valentinuzzi, et al.
Radiology and Oncology
|
April 21, 2025
Efficient gene transfer by pulse parameters for electrochemotherapy of cells <i>in vitro</i> and in muscle and melanoma tumors in mice
Masa Omerzel, Bostjan Markelc, Simona Kranjc Brezar, et al.
Bioelectrochemistry (Amsterdam, Netherlands)
|
May 13, 2021
PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice
Masa Bosnjak, Tanja Jesenko, Bostjan Markelc, et al.
Bioelectrochemistry (Amsterdam, Netherlands)
|
June 14, 2021
Corrigendum to "PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice" [Bioelectrochemistry 2021 (140) 107832]
Masa Bosnjak, Tanja Jesenko, Bostjan Markelc, et al.
Molecular Therapy. Nucleic Acids
|
October 29, 2014
Mcam Silencing With RNA Interference Using Magnetofection has Antitumor Effect in Murine Melanoma
Lara Prosen, Bostjan Markelc, Tanja Dolinsek, et al.
Page
of 7